Ranolazine Implantable Cardioverter-Defibrillator Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,012

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Ischemic CardiomyopathyNonischemic CardiomyopathyHeart Failure
Interventions
DRUG

Ranolazine

At enrollment, patients will be randomized to ranolazine or placebo. In the active drug arm each patient will be started on a 500 mg twice a day dose for one week with subsequent increase to 1000 mg twice a day at beginning of second week.

Trial Locations (90)

10021

Weill Cornell Medical College/New York Presbyterian Hospital, New York

10025

St. Luke's-Roosevelt Hospital, New York

11203

SUNY Downstate Medical Center, Brooklyn

11215

New York Methodist Hospital, Brooklyn

11219

Maimonides Medical Center, Brooklyn

11794

Stony Brook University Medical Center,, Stony Brook

12601

Hudson Valley Heart Center, Poughkeepsie

14642

University of Rochester, Rochester

15213

University of Pittsburgh Medical Center-Presbyterian, Pittsburgh

15240

VA Pittsburgh Healthcare Center, Pittsburgh

17602

Lancaster Heart & Stroke Foundation, Lancaster

18901

Doylestown Cardiology Associates - VIAA, Doylestown

Doylestown Health Cardiology/Central Bucks, Doylestown

19001

Abington Medical Specialists, Abington

19096

Lankenau Institute for Medical Research, Wynnewood

19102

Drexel University College of Medicine, Philadelphia

19107

Thomas Jefferson University, Philadelphia

20010

Washington Electrophysiology/Cardiovascular Research Institute, Washington D.C.

20735

MedStar Southern Maryland Hospital Center, Clinton

20889

Walter Reed NMMC, Portsmouth

21201

University of Maryland Medical Center, Baltimore

21287

Johns Hopkins University, Baltimore

22908

University of Virginia Health System, Charlottesville

23219

Virginia Commonwealth University, Richmond

23320

Cardiovascular Associates Ltd., Chesapeake

25304

CAMC Institute, Charleston

27705

Durham VA Medical Center, Durham

27710

Duke University Medical Center, Durham

30912

Georgia Health Sciences University, Augusta

31201

Georgia Arrhythmia Consultants, Macon

32209

University of Florida Health Science Center at Jacksonville, Jacksonville

32308

Tallahassee Research Institute, Inc., Tallahassee

32610

University of Florida/Cardiovascular Medicine, Gainesville

32803

Florida Hospital, Orlando

33511

Bay Area Cardiology Associates, P.A., Brandon

33805

Watson Clincia Center for Research Inc., Lakeland

37232

Vanderbilt University Medical Center, Nashville

38138

The Stern Cardiovascular Center, Germantown

39216

University of Mississippi Medical Center, Jackson

40503

Central Baptist Hospital, Lexington

43615

The Toledo Hospital/Northwest Ohio Cardiology Consultants, Toledo

44109

The MetroHealth System - Heart and Vascular Dept., Cleveland

45219

The Lindner Center for Research & Education, Cincinnati

45267

University of Cincinnati, Cincinnati

46342

LaPorte Hospital, Hobart

46845

Peakview Research Center, Fort Wayne

48073

William Beaumont Hospital - Royal Oak, Royal Oak

48197

Michigan Heart, Ypsilanti

48202

Henry Ford Hospital, Detroit

52242

University of Iowa, Iowa City

53215

Aurora St. Luke's Medical Center, Milwaukee

53402

Wheaton Franciscan All Saints, Racine

54449

Marshfield Clinic, Marshfield

55455

University of Minnesota, Minneapolis

55805

St. Luke's Hospital Association of Duluth, Duluth

60637

University of Chicago Hospital, Chicago

64114

Kansas City Heart Foundation, Kansas City

65212

University of Missouri, Columbia

70112

Louisiana State University Health Sciences Center- New Orleans, New Orleans

72205

Arkansas Cardiology, Little Rock

75230

Cardiopulmonary Research Science and Technology Inst., Dallas

77090

Medicus Alliance CRO, Inc, Houston

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

80909

University of Colorado Health - MHS, Colorado Springs

85724

University of Arizona, Tucson

90017

Good Samaritan Hospital, Los Angeles

91105

Huntington Memorial Hospital, Pasadena

94303

Sequoia Hospital, East Palo Alto

95210

Delta Heart and Medical Clinic, Stockton

95819

Regional Cardiology Associates, Sacramento

97239

Oregon Health & Science University, Portland

Portland VA Medical Ctr, Portland

98405

Cardiac Study Center, Tacoma

99204

Kootenai Heart Clinics, LLC, Spokane

06610

Bridgeport Hospital, Bridgeport

06102

Hartford Hospital, Hartford

02111

Tufts-New England Medical Center, Boston

01805

Lahey Clinic, Burlington

01655

University of Massachusetts-Worchester, Worcester

08043

Cooper University Hospital, Camden

07962

Morristown Memorial Hospital- Gagnon Cardiovascular Institute, Morristown

07450

The Valley Hospital, Ridgewood

02886

Brigham and Women's Cardiovascular Associates, Warwick

T2N 4Z6

University of Calgary, Calgary

T5H 3V9

Royal Alexandra Hospital, Edmonton

K7L 2V7

Queen's University, Kingston

H1T 1C8

Montreal Heart Institute, Montreal

H3G1A4

McGill University Health Centre, Montreal

J1H5N4

CHUS (Sherbrooke University), Sherbrooke

G1V 4G5

IUCPQ, Québec

All Listed Sponsors
lead

University of Rochester

OTHER

NCT01215253 - Ranolazine Implantable Cardioverter-Defibrillator Trial | Biotech Hunter | Biotech Hunter